No Detail Found!

Clinical and Biochemical Characteristics of COVID-19 Patients During the Delta-Omicron Wave with Risk Assessment of Adverse Outcomes

Author(s)
Sahar Iqbal Department of Pathology, Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan
Saeed Khan Department of Pathology, Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan
Muhammad Asif Qureshi Department of Pathology, Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan
Muneeba Ahsan Sayeed Department of Infectious Diseases, Sindh Infectious Diseases Hospital and Research Centre, Karachi, Pakistan
Bilal Ahmed Khan Department of Pathology, Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan
Sidra Zaheer School of Public Health, Dow University of Health Sciences, Karachi, Pakistan
Hafsa Faruqui Department of Pathology, Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan
Abdul Wahid Rajput Department of Infectious Diseases, Sindh Infectious Diseases Hospital and Research Centre, Karachi, Pakistan
Abstract
Objective: To compare clinical and biochemical characteristics of hospitalised COVID-19 patients and risk assessment of disease outcomes Study Design: Descriptive study. Place and Duration of the Study: Department of Pathology, Dow International Medical College and Sindh Infectious Diseases Hospital and Research Centre, from January to March 2022 Methodology: SARS CoV-2 PCR-positive hospitalised patients were enrolled. Delta or omicron variants infected patients were followed till the last recorded event of hospitalisation. After a detailed history, clinical and biochemical pro les were recorded during the hospitalisation. Length of hospitalisation, ICU admission and in-hospital mortality were taken as outcomes and odd ratios were calculated. Results: During the study period, omicron was the predominant SARS CoV-2 variant. Omicron-infected patient were older (67 vs. 62 years) and had a signi cantly shorter duration between appearance of symptoms and hospitalisation v(5s. 8 days), when compared with the delta patients. Median values of LDH, ferritin and TLC were signi cantly higher in delta patients (p<0D.e0l5ta). infected patients have a 3.9 times more risk of prolonged hospital stay. In patients with increased TLC, the risk of prolonged hospitalisation and ICU admission was found 16% and 23%, respectively. However, the aOR for ICU admission and in- Hospital mortality were not found signi cant for the delta and omicron infected patients. Conclusion: The clinical course and biochemical pro les are diverse in delta and omicron patients. Hospitalised patients with omicron infection exhibit shorter stays. High values of TLC are found associated with an increased risk of longer hospital stay and ICU admissions.
Publication Details
Page(s) 297-302
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 33, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
COVID-19, Outcomes, Hospitalised patients, Delta variant, biochemical markers, In-hospital mortality, Omicron variant
0

Citations

0

Downloads

108

Views